ARTICLES BY THIS AUTHOR
- 1/29/2020
CVS Caremark's RxZero offers PBM members no-cost diabetes medications
A new plan design from CVS Caremark eliminates member cost as a barrier to medication adherence, without raising costs for benefits plan sponsors or increasing premiums or deductibles. - 1/29/2020
2020 could be a blockbuster year for drug approvals
Sixty-four drugs have been filed with the FDA and have anticipated approval dates in 2020, according to OptumRx's Drug Pipeline Insights Report. - 1/28/2020
Upsher-Smith launches generic Kapvay
Clonidine hydrochloride ER tablets had a market value of approximately $30 million for the 12 months ended November 2019, according to IQVIA. - 1/28/2020
Boehringer Ingelheim, Lilly get FDA green light for Trijardy
The FDA has approved Trijardy, the only triple-combination tablet with Jardiance for adults with Type 2 diabetes. - 1/28/2020
Hy-Vee to open more Dollar Fresh stores in Iowa
Hy-Vee is set to rebrand six acquired Shopko stores under its Dollar Fresh banner. - 1/28/2020
FDA approves new indication for Lundbeck’s Sabril
Lundbeck's Sabril 's new indication approval closes the age gap for patients. - 1/28/2020
Alembic gets FDA nod for two generics
Azithromycin tablets and bosentan tablets have a market value of about $2 million, and $68 million respectively, for the 12 months ended September 2019. - 1/28/2020
Par launches authorized generic Carafate
Sucralfate oral suspension had a market value of roughly $285 million for the 12 months ended Nov. 30, 2019, according to IQVIA. - 1/28/2020
CVS Health to offer free heart screenings in February
Free heart screenings will be available on select Thursdays in February at MinuteClinic locations nationwide. - 1/27/2020
Hy-Vee promotes company veteran to vice chairman role
Hy-Vee executive Jay Marshall has been elevated to vice chairman for the grocery chain.